U.S. flag

An official website of the United States government

NM_001256317.3(TMPRSS3):c.917C>T (p.Ala306Val) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Dec 13, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003708734.2

Allele description [Variation Report for NM_001256317.3(TMPRSS3):c.917C>T (p.Ala306Val)]

NM_001256317.3(TMPRSS3):c.917C>T (p.Ala306Val)

Gene:
TMPRSS3:transmembrane serine protease 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
21q22.3
Genomic location:
Preferred name:
NM_001256317.3(TMPRSS3):c.917C>T (p.Ala306Val)
HGVS:
  • NC_000021.9:g.42382100G>A
  • NG_011629.2:g.18992C>T
  • NM_001256317.3:c.917C>TMANE SELECT
  • NM_024022.4:c.917C>T
  • NM_032404.3:c.536C>T
  • NM_032405.2:c.917C>T
  • NP_001243246.1:p.Ala306Val
  • NP_076927.1:p.Ala306Val
  • NP_115780.1:p.Ala179Val
  • NP_115781.1:p.Ala306Val
  • NC_000021.8:g.43802209G>A
Protein change:
A179V
Molecular consequence:
  • NM_001256317.3:c.917C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_024022.4:c.917C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_032404.3:c.536C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_032405.2:c.917C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004485988Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Dec 13, 2022)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Autosomal recessive postlingual hearing loss (DFNB8): compound heterozygosity for two novel TMPRSS3 mutations in German siblings.

Elbracht M, Senderek J, Eggermann T, Thürmer C, Park J, Westhofen M, Zerres K.

J Med Genet. 2007 Jun;44(6):e81.

PubMed [citation]
PMID:
17551081
PMCID:
PMC2752172

A sensitive and specific diagnostic test for hearing loss using a microdroplet PCR-based approach and next generation sequencing.

Schrauwen I, Sommen M, Corneveaux JJ, Reiman RA, Hackett NJ, Claes C, Claes K, Bitner-Glindzicz M, Coucke P, Van Camp G, Huentelman MJ.

Am J Med Genet A. 2013 Jan;161A(1):145-52. doi: 10.1002/ajmg.a.35737. Epub 2012 Dec 3.

PubMed [citation]
PMID:
23208854
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004485988.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This variant has not been reported in the literature in individuals affected with TMPRSS3-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 306 of the TMPRSS3 protein (p.Ala306Val). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TMPRSS3 protein function. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Ala306 amino acid residue in TMPRSS3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17551081, 23208854, 24526180, 28246597). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024